
Bausch + Lomb Corp
NYSE:BLCO

Bausch + Lomb Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10.9
20.93
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Bausch + Lomb Corp hold over its rivals?
What risks and challenges
does Bausch + Lomb Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Bausch + Lomb Corp.
Provide an overview of the primary business activities
of Bausch + Lomb Corp.
What unique competitive advantages
does Bausch + Lomb Corp hold over its rivals?
What risks and challenges
does Bausch + Lomb Corp face in the near future?
Has there been any significant insider trading activity
in Bausch + Lomb Corp recently?
Summarize the latest earnings call
of Bausch + Lomb Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Bausch + Lomb Corp.
Provide P/S
for Bausch + Lomb Corp.
Provide P/E
for Bausch + Lomb Corp.
Provide P/OCF
for Bausch + Lomb Corp.
Provide P/FCFE
for Bausch + Lomb Corp.
Provide P/B
for Bausch + Lomb Corp.
Provide EV/S
for Bausch + Lomb Corp.
Provide EV/GP
for Bausch + Lomb Corp.
Provide EV/EBITDA
for Bausch + Lomb Corp.
Provide EV/EBIT
for Bausch + Lomb Corp.
Provide EV/OCF
for Bausch + Lomb Corp.
Provide EV/FCFF
for Bausch + Lomb Corp.
Provide EV/IC
for Bausch + Lomb Corp.
Show me price targets
for Bausch + Lomb Corp made by professional analysts.
What are the Revenue projections
for Bausch + Lomb Corp?
How accurate were the past Revenue estimates
for Bausch + Lomb Corp?
What are the Net Income projections
for Bausch + Lomb Corp?
How accurate were the past Net Income estimates
for Bausch + Lomb Corp?
What are the EPS projections
for Bausch + Lomb Corp?
How accurate were the past EPS estimates
for Bausch + Lomb Corp?
What are the EBIT projections
for Bausch + Lomb Corp?
How accurate were the past EBIT estimates
for Bausch + Lomb Corp?
Compare the revenue forecasts
for Bausch + Lomb Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Bausch + Lomb Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Bausch + Lomb Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of Bausch + Lomb Corp compared to its peers.
Compare the P/E ratios
of Bausch + Lomb Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing Bausch + Lomb Corp with its peers.
Analyze the financial leverage
of Bausch + Lomb Corp compared to its main competitors.
Show all profitability ratios
for Bausch + Lomb Corp.
Provide ROE
for Bausch + Lomb Corp.
Provide ROA
for Bausch + Lomb Corp.
Provide ROIC
for Bausch + Lomb Corp.
Provide ROCE
for Bausch + Lomb Corp.
Provide Gross Margin
for Bausch + Lomb Corp.
Provide Operating Margin
for Bausch + Lomb Corp.
Provide Net Margin
for Bausch + Lomb Corp.
Provide FCF Margin
for Bausch + Lomb Corp.
Show all solvency ratios
for Bausch + Lomb Corp.
Provide D/E Ratio
for Bausch + Lomb Corp.
Provide D/A Ratio
for Bausch + Lomb Corp.
Provide Interest Coverage Ratio
for Bausch + Lomb Corp.
Provide Altman Z-Score Ratio
for Bausch + Lomb Corp.
Provide Quick Ratio
for Bausch + Lomb Corp.
Provide Current Ratio
for Bausch + Lomb Corp.
Provide Cash Ratio
for Bausch + Lomb Corp.
What is the historical Revenue growth
over the last 5 years for Bausch + Lomb Corp?
What is the historical Net Income growth
over the last 5 years for Bausch + Lomb Corp?
What is the current Free Cash Flow
of Bausch + Lomb Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for Bausch + Lomb Corp.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
4.3B USD | 15.9 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
34.8B CHF | 17.8 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
5.8T JPY | 17.5 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
136.2B DKK | 17.3 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD | 15.9 |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5.9B GBP | 210.6 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.6B CHF | 30.8 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.1B CNY | 27.9 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.6B USD | 10.1 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.5B USD | 20.7 |
|
KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.5T KRW | -61.3 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
Average EV/EBITDA:
38.4
15.9
|
19%
|
0.8 | |
CH |
![]() |
Alcon AG
SIX:ALC
|
17.8
|
10%
|
1.8 |
|
JP |
![]() |
Hoya Corp
TSE:7741
|
17.5
|
9%
|
1.9 |
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
17.3
|
9%
|
1.9 |
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
15.9
|
15%
|
1.1 |
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
210.6
|
11%
|
19.1 |
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
30.8
|
31%
|
1 |
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
27.9
|
18%
|
1.5 |
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
10.1
|
21%
|
0.5 |
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
20.7
|
12%
|
1.7 |
|
KR |
H
|
HLB Inc
KOSDAQ:028300
|
Negative Multiple: -61.3 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.